Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000899243-18-004949

Chief Financial Officer sold 316 shares at $51.85 ($16,385)

From the SEC's structured data for this filing

Trades in this filing

Regnante Keith · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-02-16 Sale : show line 1 in the form −316 $51.85 $16,385 16,984 D
Open-market sales · 316 sh · avg $51.85 · $16,385
Loading xslF345X03/doc4.xml…